Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

Recruiting now · Phase 4

Conditions studied: Liver Transplantation, Acute Kidney Injury

In brief

To verify whether albumin administration to achieve serum concentration above 30g/L (treated group) and its maintenance within plasmatic physiologic range (above 30 g/L) for five days diminishes rate of AKI at Day 7 after liver transplantation as compared to restrained albumin administration (when serum concentration is at 20 g/L or below (control)).

Key facts

Study ID
NCT06535945
Run by
Rennes University Hospital
People needed
400
Starts
2025-03-26
Expected to finish
2028-04-26
Last updated by the study team
2026-06-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.